Haleon (NYSE: HLN) reports executive PDMR share dealings in Share Reward Plan

Rhea-AI Filing Summary

Haleon plc reported routine share transactions by two senior executives under its Share Reward Plan. On 9 December 2025, General Counsel Adrian Morris and Chief Marketing Officer Tamara Rogers each acquired 35 partnership shares in Haleon at a price of £3.57201 per ordinary share and received 35 matching shares at no cost. These ordinary shares have a nominal value of £0.01 each and are listed on the London Stock Exchange. The disclosure is made in line with UK Market Abuse Regulation requirements for transactions by persons discharging managerial responsibilities.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	10 December 2025 - “Director/PDMR Shareholding”

99.1

​Haleon plc: Director/PDMR Shareholding

​

10 December 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

On 10 December 2025, the Company received notification of the following transactions as detailed below.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Adrian Morris
2	Reason for the notification
a)	Position/status	General Counsel - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BMX86B70
	b)	Nature of the transaction	Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
	c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.57201	35
			£Nil	35 (Matching Shares)
d)		Aggregated information
	- Aggregated volume	70
	- Price
	e)	Date of the transaction	9 December 2025
	f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Tamara Rogers
2	Reason for the notification
a)	Position/status	Chief Marketing Officer - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BMX86B70
	b)	Nature of the transaction	Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
	c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.57201	35
			£Nil	35 (Matching Shares)
d)		Aggregated information
	- Aggregated volume	70
	- Price
	e)	Date of the transaction	9 December 2025
	f)	Place of the transaction	London Stock Exchange (XLON)

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: December 10, 2025	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What did Haleon plc (HLN) announce in this Form 6-K?

Haleon disclosed transactions by two senior executives who acquired partnership shares and were awarded matching shares in Haleon plc under the Company's Share Reward Plan, in line with UK Market Abuse Regulation.

Which Haleon (HLN) executives were involved in the reported share transactions?

The transactions involved Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer, both classified as Persons Discharging Managerial Responsibilities (PDMRs).

How many Haleon (HLN) shares did each PDMR acquire and at what price?

Each PDMR acquired 35 partnership shares in Haleon at a price of £3.57201 per ordinary share and received an additional 35 matching shares at £Nil under the Share Reward Plan.

What type of shares were involved in the Haleon (HLN) PDMR transactions?

The transactions related to ordinary shares of £0.01 each in Haleon plc, identified by the code GB00BMX86B70 and traded on the London Stock Exchange (XLON).

When and where were the Haleon (HLN) PDMR share transactions carried out?

The transactions took place on 9 December 2025 on the London Stock Exchange (XLON) and were subsequently notified to the company and disclosed on 10 December 2025.

Why is Haleon (HLN) required to disclose these PDMR share dealings?

These dealings must be disclosed to comply with the UK Market Abuse Regulation, which requires public notification of transactions by persons discharging managerial responsibilities in listed companies.